853.60
+17.90
+(2.14%)
At close: January 30 at 5:24:48 PM GMT+2
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
121,334.00
94,176.00
132,163.00
138,316.00
Total Liabilities Net Minority Interest
55,775.00
16,496.00
25,470.00
18,534.00
Total Equity Gross Minority Interest
65,559.00
77,680.00
106,693.00
119,782.00
Total Capitalization
65,559.00
77,680.00
106,693.00
119,782.00
Common Stock Equity
65,559.00
77,680.00
106,693.00
119,782.00
Capital Lease Obligations
1,351.00
1,925.00
2,750.00
3,166.00
Net Tangible Assets
65,559.00
77,680.00
106,693.00
119,782.00
Working Capital
88,313.00
74,206.00
106,126.00
118,567.00
Invested Capital
65,559.00
77,680.00
106,693.00
119,782.00
Tangible Book Value
65,559.00
77,680.00
106,693.00
119,782.00
Total Debt
1,351.00
1,925.00
2,750.00
3,166.00
Share Issued
89,237.47
86,624.64
86,433.43
83,675.86
Ordinary Shares Number
89,237.47
86,624.64
86,433.43
83,675.86
12/31/2020 - 8/12/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LCTX.TA Lineage Cell Therapeutics, Inc.
223.00
-5.55%
EVGN.TA Evogene Ltd.
551.10
-3.49%
688235.SS BeiGene, Ltd.
190.69
+0.89%
BLRX.TA BioLineRx Ltd.
2.4000
-25.00%
KDST.TA Kadimastem Ltd
1,560.00
+3.38%
EVGN Evogene Ltd.
1.5700
+1.29%
RCUS Arcus Biosciences, Inc.
12.90
-3.59%
ALVR AlloVir, Inc.
9.42
+0.11%
ARDS Aridis Pharmaceuticals, Inc.
0.0001
-99.00%
PLUR Pluri Inc.
4.4800
+2.28%